Circulating Th1, Th2, Th9, Th17, Th22, and Treg Levels in Aortic Dissection Patients

  • Jing Ye
    Department of Cardiology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
  • Yuan Wang
    Department of Cardiology, Hubei Key Laboratory of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China
  • Zhen Wang
    Department of Cardiology, Hubei Key Laboratory of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China
  • Qingwei Ji
    Department of Cardiology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
  • Ying Huang
    Department of Cardiology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
  • Tao Zeng
    Department of Cardiology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
  • Haiying Hu
    Department of Cardiology, Handan First Hospital, Handan 056002, China
  • Di Ye
    Department of Cardiology, Hubei Key Laboratory of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China
  • Jun Wan
    Department of Cardiology, Hubei Key Laboratory of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Wuhan 430060, China
  • Yingzhong Lin
    Department of Cardiology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China

この論文をさがす

説明

<jats:p><jats:italic>Background</jats:italic>. Previous studies demonstrated that the subsets of CD4+ T helper (Th) cells are closely related to vascular diseases, including atherosclerosis and hypertension. This study is aimed at investigating the circulating Th1, Th2, Th9, Th17, Th22, and Treg levels in aortic dissection (AD) patients. <jats:italic>Methods</jats:italic>. Blood samples from AD (<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>56</mml:mn></mml:math>) and non-AD (NAD, <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mn>24</mml:mn></mml:math>) patients were collected, and the circulating levels of Th1, Th2, Th9, Th17, Th22, and Treg cells and their transcription factors and functional cytokines were measured by flow cytometric analysis, quantitative polymerase chain reaction, and enzyme-linked immunosorbent assays, respectively. In addition, the human aortic vascular smooth muscle cells (HASMCs) were treated with saline, angiotensin II (Ang II), or plasma from AD patients. <jats:italic>Results</jats:italic>. Compared with the levels in the NAD group, the Th1, Th9, Th17, Th22, and their transcription factor levels were increased and the Th2, Treg, and their transcription factor levels exhibited a decreasing trend in AD patients. In addition, higher IFN-<jats:italic>γ</jats:italic>, IL-9, IL-17, and IL-22 levels and lower IL-4 and IL-35 levels were observed in AD patients. Simple linear regression analysis and binary logistic regression analysis suggested that Th1/IFN-<jats:italic>γ</jats:italic>, IL-9, Th17/IL-17, and Th22/IL-22 positively regulated the occurrence of AD, while Th2/IL-4 and Treg/IL-35 negatively regulated the occurrence of AD. Plasma from AD patients further increased Bax mRNA levels but decreased Bcl2 and <jats:italic>α</jats:italic>-SMA mRNA levels in Ang II-treated HASMCs. <jats:italic>Conclusions</jats:italic>. Changes in Th1, Th2, Th9, Th17, Th22, and Treg activity are associated with the onset of AD. Different subsets of CD4+ T cells play different roles in the presence of AD.</jats:p>

収録刊行物

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ